Ophthalmologist Steffen Schmitz-Valckenberg Joins Moran Eye Center

Renowned expert in retinal imaging and gene therapy appointed to prestigious position at University of Utah

Published on Feb. 22, 2026

Steffen Schmitz-Valckenberg, MD, a leading ophthalmologist and expert in retinal imaging and gene therapy, has been appointed as professor of ophthalmology and visual science and the Jon M. Huntsman Presidential Chair at the John A. Moran Eye Center at the University of Utah in Salt Lake City.

Why it matters

Schmitz-Valckenberg's appointment to this prestigious position at the Moran Eye Center, one of the top ophthalmology research and treatment facilities in the country, underscores his expertise and influence in the field of ophthalmology. His work in retinal imaging and gene therapy has the potential to drive advancements in the diagnosis and treatment of various eye conditions.

The details

In his new role, Schmitz-Valckenberg will leverage his extensive experience and knowledge to further the research and clinical capabilities of the Moran Eye Center. He is known for his pioneering work in the development of advanced retinal imaging techniques and his contributions to the field of gene therapy for ocular diseases.

  • Schmitz-Valckenberg's appointment at the Moran Eye Center began in February 2026.

The players

Steffen Schmitz-Valckenberg, MD

A professor of ophthalmology and visual science and the Jon M. Huntsman Presidential Chair at the John A. Moran Eye Center at the University of Utah in Salt Lake City.

John A. Moran Eye Center

A leading ophthalmology research and treatment facility at the University of Utah in Salt Lake City.

Got photos? Submit your photos here. ›

The takeaway

Schmitz-Valckenberg's appointment to the prestigious position at the Moran Eye Center underscores his expertise and influence in the field of ophthalmology, particularly in the areas of retinal imaging and gene therapy. His work has the potential to drive significant advancements in the diagnosis and treatment of various eye conditions.